Table 3.
CD3+ | CD4+ | Foxp3+ | ROR-γ+ | |
---|---|---|---|---|
Male SHR | ||||
Control | 68 ± 1 | 38 ± 2 | 5 ± 1 | 25 ± 1 |
l-NAME | 77 ± 1* | 52 ± 2* | 4 ± 1 | 28 ± 1 |
l-NAME+ TTx | 72 ± 1*† | 41 ± 1† | 11 ± 1*† | 22 ± 1† |
Female SHR | ||||
Control | 72 ± 1 | 51 ± 2 | 4 ± 1 | 30 ± 0.7 |
l-NAME | 83 ± 1* | 56 ± 1* | 2 ± 1 | 34 ± 2 |
l-NAME+ TTx | 73 ± 1† | 48 ± 1† | 10 ± 1*† | 21 ± 2*† |
Values are means ± SE.
Difference from same sex vehicle-control;
indicates significant difference from l-NAME. CD3+ cells are expressed as % of total blood cells. CD4+ cells are expressed as % of CD3+ cells. Foxp3+ (Tregs) and ROR-γ+ cells are expressed as % CD3+CD4+ cells.